» Articles » PMID: 39852298

Bridging the Gaps in Atrial Fibrillation Management in the Emergency Department

Overview
Date 2025 Jan 24
PMID 39852298
Authors
Affiliations
Soon will be listed here.
Abstract

Atrial fibrillation (AF) frequently presents in emergency departments (EDs), contributing significantly to adverse cardiovascular outcomes. Despite established guidelines, ED management of AF often varies, revealing important gaps in care. This review addresses specific challenges in AF management for patients in the ED, including the nuances of rate versus rhythm control, the timing of anticoagulation initiation, and patient disposition. The updated 2024 European Society of Cardiology (ESC) guidelines advocate early rhythm control for select patients while recommending rate control for others; however, uncertainties persist, particularly regarding these strategies' long-term impact on outcomes. Stroke prevention through timely anticoagulation remains crucial, though the ideal timing, especially for new-onset AF, needs further research. Additionally, ED discharge protocols and follow-up care for AF patients are often inconsistent, leaving many without proper long-term management. Integration of emerging therapies, including direct oral anticoagulants and advanced antiarrhythmic drugs, shows potential but remains uneven across EDs. Innovative multidisciplinary models, such as "AF Heart Teams" and observation units, could enhance care but face practical challenges in implementation. This review underscores the need for targeted research to refine AF management, optimize discharge protocols, and incorporate novel therapies effectively. Standardizing ED care for AF could significantly reduce stroke risk, lower readmission rates, and improve overall patient outcomes.

References
1.
Atzema C, Barrett T . Managing atrial fibrillation. Ann Emerg Med. 2015; 65(5):532-9. PMC: 4519094. DOI: 10.1016/j.annemergmed.2014.12.010. View

2.
Leung M, van Rosendael P, Abou R, Ajmone Marsan N, Leung D, Delgado V . The Impact of Atrial Fibrillation Clinical Subtype on Mortality. JACC Clin Electrophysiol. 2018; 4(2):221-227. DOI: 10.1016/j.jacep.2017.09.002. View

3.
Peterson E, Ho P, Barton M, Beam C, Burgess L, Casey Jr D . ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circulation. 2014; 130(22):1984-94. PMC: 4500543. DOI: 10.1161/CIR.0000000000000139. View

4.
Vaughan E, Naik A, Lewis C, Foreyt J, Samson S, Hyman D . Telemedicine Training and Support for Community Health Workers: Improving Knowledge of Diabetes. Telemed J E Health. 2019; 26(2):244-250. PMC: 7044768. DOI: 10.1089/tmj.2018.0313. View

5.
Chao T, Liu C, Lin Y, Chang S, Lo L, Hu Y . Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study. Circulation. 2018; 138(1):37-47. DOI: 10.1161/CIRCULATIONAHA.117.031658. View